Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Discover how using loyalty programs with credit card points can boost your rewards. Make your points go further.
20,311 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
A fresh Federal Reserve briefing shows a modest emergency cushion among households, but retirement readiness remains ...
Cuba warns that an intensifying oil embargo is pushing its health system toward collapse, threatening everyday safety...
Ripple is channeling billions into infrastructure to connect traditional finance with blockchain systems, reshaping t...
On a day when the market waded through tensions abroad and a stubborn oil rally, energy names bucked the trend. This ...
Tempo, a Layer 1 blockchain backed by Stripe, has officially launched its mainnet with a sharp focus on AI agent paym...
Investors often react to headlines about Coinbase and Circle with a knee-jerk fear or optimism. This piece explains w...
If SpaceX goes public, many investors want a straightforward path to participate. This guide lays out practical, safe...
York Space Systems stock tumbled after a disappointing quarterly report. This guide explains what happened, why it ma...
This week brought a sharp move in Poet Technologies shares as a dilutive financing announcement rattled investors. Le...
Celebrity comebacks aren’t just headlines—they reshape money decisions. This piece breaks down how david beckham’s co...
SpaceX's Starlink is no longer just a satellite internet service. As Oppenheimer analysts suggest, it could upend a $...